R.O.W. BIOPHARMA Trademark

Trademark Overview

On Friday, August 28, 2020, a trademark application was filed for R.O.W. BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the R.O.W. BIOPHARMA trademark a serial number of 79299431. The federal status of this trademark filing is REGISTERED as of Tuesday, July 20, 2021. This trademark is owned by Swixx BioPharma AG. The R.O.W. BIOPHARMA trademark is filed in the Advertising, Business and Retail Services category with the following description:

Advertising relating to pharmaceutical products; commercial business management; commercial administration of the licensing of pharmaceutical products, dietetic food adapted for medical purposes, dietary and nutritional supplements, medical supplies, medical devices, medical, sanitary, and veterinary preparations, and cosmetics, of others; office functions provided to the healthcare industry
r.o.w. biopharma

General Information

Serial Number79299431
Word MarkR.O.W. BIOPHARMA
Filing DateFriday, August 28, 2020
Status700 - REGISTERED
Status DateTuesday, July 20, 2021
Registration Number6422518
Registration DateTuesday, July 20, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 4, 2021

Trademark Statements

Disclaimer with Predetermined Text"BIOPHARMA"
Goods and ServicesAdvertising relating to pharmaceutical products; commercial business management; commercial administration of the licensing of pharmaceutical products, dietetic food adapted for medical purposes, dietary and nutritional supplements, medical supplies, medical devices, medical, sanitary, and veterinary preparations, and cosmetics, of others; office functions provided to the healthcare industry
Pseudo MarkROW BIO PHARMACY

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, January 11, 2021
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSwixx BioPharma AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameSwixx BioPharma AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameSwixx BioPharma AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Monday, December 13, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, November 18, 2021FINAL DISPOSITION NOTICE SENT TO IB
Thursday, November 18, 2021FINAL DISPOSITION PROCESSED
Wednesday, October 20, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, July 23, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, July 20, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, May 4, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Monday, May 3, 2021NOTIFICATION PROCESSED BY IB
Wednesday, April 14, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 14, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 31, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 30, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 17, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 17, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 17, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 17, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 17, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, March 7, 2021REFUSAL PROCESSED BY IB
Friday, February 5, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 5, 2021REFUSAL PROCESSED BY MPU
Friday, January 15, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 15, 2021APPLICATION FILING RECEIPT MAILED
Thursday, January 14, 2021NON-FINAL ACTION WRITTEN
Monday, January 11, 2021ASSIGNED TO EXAMINER
Monday, January 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 7, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 10, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

biopharma medical products commercial pharmaceutical preparations devices sanitary cosmetics veterinary functions